Abilitech Assist for Muscular Dystrophy

N/A

Recruiting

Research Sponsored by AbiliTech Medical Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline before device intervention (30 days), and after device intervention (60 days)

Awards & highlights

Study Summary

This trial will evaluate the function of the upper limbs of subjects with neuromuscular disorders, with and without use of the Abilitech Assist device, in order to assess the device's safety and efficacy.

Eligible Conditions

Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy
Becker Muscular Dystrophy
Duchenne Muscular Dystrophy
Limb-Girdle Muscular Dystrophy
Cerebral Palsy
Spinal Muscular Atrophy

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline before device intervention (30 days), and after device intervention (60 days)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline before device intervention (30 days), and after device intervention (60 days)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline before device intervention (30 days), and after device intervention (60 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Canadian Occupational Performance Measure (COPM)

Roll Evaluation of Activities of Life (REAL) assessment

Trial Design

1Treatment groups

Experimental Treatment

Group I: Abilitech AssistExperimental Treatment1 Intervention

The Abilitech™ Assist device is a passively powered orthotic device designed to support and assist the arms of patients with neuromuscular weakness for activities of daily living.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Richard M. Schulze Family FoundationUNKNOWN

AbiliTech Medical Inc.Lead Sponsor

2 Previous Clinical Trials

24 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the participant limit for this clinical trial?

"Affirmative. Clinicaltrials.gov data confirms that this research is currently seeking participants since its posting on May 26th 2022 and most recent edit to the information on December 1st 2022. There are 35 slots available in a single medical centre for prospective patients."

Answered by AI

Is this medical experiment open for patient recruitment?

"Affirmative. Clinicaltrials.gov data indicates that the clinical trial, initially posted on May 26th 2022 is presently recruiting patients for participation. This study requires 35 participants from one medical site to complete it."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Schulze Muscular Dystrophy Ability Clinical Study

2022. "Schulze Muscular Dystrophy Ability Clinical Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05409079.

All > Muscular Dystrophy